Table 3.
Procedures for the correction of pathologic misdiagnosis in previously diagnosed group
| Subtypes | Primary procedures | N | Secondary procedures | N |
|---|---|---|---|---|
|
fXLAS |
Correction after proband diagnosed |
8 |
plus skin biopsy |
3 |
| |
|
|
plus recheck of EM |
5 |
| |
|
|
later found FH |
6 |
| |
|
|
rule out confounding factors |
2 |
| |
|
|
later developed ear/eye damage |
1 |
| |
Recheck of EM/COL in renal tissue during follow-up |
10 |
recheck EM in renal tissue |
8 |
| |
|
|
recheck kidney collagen stain |
2 |
| |
Renal re-biopsy with EM/COL exams |
3 |
rule out confounding factors |
2 |
| |
|
|
plus skin biopsy |
1 |
| |
Skin biopsy alone |
2 |
|
|
|
mXLAS |
Correction after proband diagnosed |
1 |
plus skin biopsy |
1 |
| |
Renal re-biopsy with EM/COL |
13 |
plus skin biopsy |
12 |
| |
|
|
later found FH |
5 |
| |
Skin biopsy alone |
3 |
later developed ear/eye damage |
2 |
| |
|
|
plus recheck of EM/COL |
3 |
|
ARAS |
Renal re-biopsy with EM/COL exams |
8 |
later found FH |
6 |
| |
|
|
rule out confounding factors |
4 |
| |
Recheck EM/COL exams in renal tissue |
3 |
later found FH |
1 |
| Proband | 1 | later found FH | 1 |
N, patients number; mXLAS, male patients with X-linked Alport syndrome; fXLAS, female patients with X-linked Alport syndrome; ARAS, autosomal recessive Alport syndrome FH, positive family history; EM, electronic microscopy; COL,collagen-IV immunofluorescence.